Not Yet Recruiting
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
NCT07570862
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
- Locations
-
Not specified